bioAffinity Technologies, Inc. 8-K

What Happened

• On March 13, 2026, bioAffinity Technologies, Inc. (a Delaware corporation) issued a press release that included financial information for the year ended December 31, 2025.
• The company furnished that press release as Exhibit 99.1 to a Current Report on Form 8‑K (Item 2.02 — Results of Operations and Financial Condition). For the detailed figures and commentary, investors should review Exhibit 99.1 of the filing.

Key Details

• Filing date: March 13, 2026.
• Reporting period referenced: Year ended December 31, 2025.
• Document attached to the 8‑K: Exhibit 99.1 (press release); interactive XBRL cover page data also furnished (Exhibit 104).
• Form 8‑K Item reported: 2.02 — Results of operations and financial condition (press release with financial information).

Why It Matters

• This 8‑K signals that bioAffinity has publicly released its year‑end financials and related commentary; those details (earnings, revenue, net income/loss, cash position, or any forward guidance) are in the attached press release.
• Retail investors should read Exhibit 99.1 to see the actual figures and management commentary, and watch for follow‑up filings (e.g., 10‑K) for audited financial statements and additional disclosures.